Form 4: Upstream Bio Insider Sells Shares for Tax Withholding

Upstream Bio's Chief Medical Officer, Aaron Deykin, sold 895 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Aaron Deykin, Chief Medical Officer of Upstream Bio, Inc., reported a transaction on June 16, 2026.
• The transaction involved the sale of 895 shares of common stock.
• These shares were sold to satisfy tax withholding obligations upon the vesting of restricted stock units.
• The sales were executed automatically under the company's 'sell-to-cover' policy and were not at the discretion of Mr. Deykin.
• Following this transaction, Mr. Deykin beneficially owns 33,197 shares of common stock.
• This total includes 1,405 shares previously acquired through the Issuer's 2024 Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While an insider sale can be a negative signal, the clear explanation of it being an automatic 'sell-to-cover' transaction for tax purposes mitigates significant concern.

Positives

• The sale was an automatic process to cover tax obligations, indicating a standard procedure rather than a discretionary sell-off.
• The company has a policy ('sell-to-cover') in place to manage these tax liabilities efficiently.
• The reporting person still beneficially owns a significant number of shares (33,197) after the transaction.

Negatives

• An insider sold company stock, which can sometimes be perceived negatively by the market, even if for tax reasons.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Management Comments

• The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.
• Such sales were automatic and not at the discretion of the Reporting Person.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. The 'sell-to-cover' mechanism is a common practice for executives to manage tax liabilities arising from equity compensation, particularly with the increasing value of stock-based awards.

Stakeholder Impact

• Shareholders: The sale is for tax purposes and automatic, so it is unlikely to signal a lack of confidence by management in the company's future. The remaining beneficial ownership by the executive remains substantial.

Key Dates

Keywords

Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Upstream Bio, Aaron Deykin, Beneficial Ownership